Vodobatinib
Catalog No. A22504
Vodobatinib, also known as K-0706, is a novel 3rd generation (3G) TKI effective against wild-type and mutated BCR-ABL1 with limited off-target activity.
| Catalog Num | A22504 |
|---|---|
| M. Wt | 453.926 |
| Formula | C27H20ClN3O2 |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 1388803-90-4 |
| Synonyms | Vodobatinib, K-0706, K0706, K0706, |
| SMILES | CC1=C(C=C(C(NNC(C2=C(Cl)C=CC=C2C)=O)=O)C=C1)C#CC(C=N3)=CC4=C3C=CC=C4 |
Vodobatinib, also known as K-0706, is a novel 3rd generation (3G) TKI effective against wild-type and mutated BCR-ABL1 with limited off-target activity.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 22.03 mL | 110.15 mL | 220.3 mL |
| 0.5 mM | 4.41 mL | 22.03 mL | 44.06 mL |
| 1 mM | 2.2 mL | 11.02 mL | 22.03 mL |
| 5 mM | 0.44 mL | 2.2 mL | 4.41 mL |
*The above data is based on the productmolecular weight 453.926. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.